Mutations in *BRCA1*confer a high lifetime risk for both breast and ovarian cancer. Many different *BRCA1*mutations have been described in families with early-onset breast and ovarian cancer \[[@B1],[@B2]\]. The presence of recurrent mutations in *BRCA1*suggests the presence of founder effects. *BRCA1*\"de novo\" mutations are very rare. 66 families were studied in Szczecin with strong aggregations of breast/ovarian cancers. Mutations were found in 35 (53%) of the 66 families. Three *BRCA1*abnormalities - 5382insC, C61G, and 4153delA - accounted for 51, 20, and 11% of the identified mutations, respectively \[[@B3]\]. Similar results were reported in Gliwice, Gdańsk and Poznań centres \[[@B4]-[@B6]\]. Additional evaluation of 200 families originating from all regions of Poland (with at least 3 breast/ovarian cancers) revealed that constitutional *BRCA1*mutations can be detected in 64% (128/200) of these families, and 90% of all of them carried one of the 3 common founder mutations (5382insC, C61G and 4153delA) \[[@B7]\]. Genetic testing for these *BRCA1*mutations is inexpensive and relatively simple in Poland (\~100 Euro including genetic counselling). It is based on the \"multiplex PCR\" method with almost 100% specificity in detection of three common Polish *BRCA1*mutations. In 2006, 3500 unselected incident cases of early-onset breast cancers were screened for presence of the three common Polish *BRCA1*mutations. The proportion of cases with an identified mutation was 5.7% \[[@B8]\]. In a similar study of 500 unselected ovarian cancers, common *BRCA1*mutations were detected in 13% of cases \[[@B9],[@B10]\]. It is possible to increase women\'s awareness about hereditary cancer through the popular press. Genetic testing was offered to 5000 Polish women through an announcement placed in a popular women\'s magazine „Twój Styl". A total of 5024 women who qualified received a free genetic test for three mutations in *BRCA1*which are common in Poland. Out of these, 198 women (3.9%) were found to carry a *BRCA1*mutation. Genetic testing for *BRCA1*mutations in Poland should be recommended for adult females who:

• fulfil clinical criteria of hereditary breast/ovarian cancer,

• are affected with breast or ovarian cancer,

• are healthy but have at least one relative with breast/ovarian cancer (breast cancer diagnosed under age 50).

Genetic testing for presence of *BRCA1*mutations should be preceded and followed by genetic counselling. So far nearly 4500 *BRCA1*mutation carriers have been detected at the International Hereditary Cancer Centre in Szczecin (the world\'s largest registry of females diagnosed and under surveillance by a single centre).

We believe that the \"Polish model\" of solving the problem of *BRCA1/BRCA2*testing can be valuable for many populations with a relatively high level of genetic homogeneity.
